Specific data captured in any rare disease, including genetic condition. Longitudinal patient histories combined with detailed tracking of patient management.
Many diseases have sub-cohorts with very specific characteristics. Tudor Health uses over-sampling and novel HCP engagement methods to capture longitudinal diagnostic and treatment data in each niche cohort.
Each oncology sector comprises many sub-cohorts, data from each can be captured by the Tudor Health methodology, including complex diagnostic and treatment histories across all stages of disease.
Tudor Health captures longitudinal patient-level data directly from HCPs using a unique proprietary method that is designed for use in all disease areas, all specialities, and all countries.
Our approach to capturing data differs from other sources in these key respects:
Our data capture is NOT drawn directly from EMR software. This allows us to capture data from institutions with any EMR technology. We establish a strong relationship with individual HCPs to capture data, not a technology link.
Our longitudinal data are captured by updating data on the same set of patients. This gives us the opportunity to gradually expand the extent of the data held on each patient, which gives us greater depth of analytical options.
Our data capture is NOT drawn directly from EMR software. This allows us to capture data from institutions with any EMR technology. We establish a strong relationship with individual HCPs to capture data, not a technology link.
Our longitudinal data are captured by updating data on the same set of patients. Data are held at the patient level and expand as we track patients over time. Trends are measured not inferred.
We use complex sampling techniques to ensure that we have sufficient data on rare cohorts to give analytical reliability. By over-sampling rare cohorts we provide insights at a level that other sources find difficult.
Tudor Health platform has a novel internal AI engine that monitors data quality at the time of data capture. Improving data quality and reducing timelines.
We use complex sampling techniques to ensure that we have sufficient data on rare cohorts to give analytical reliability. By over-sampling rare cohorts we provide insights at a level that other sources find difficult.
The Tudor Health data model uses an identical data-capture method in all countries. This makes the data consistent within country and comparable across countries.
Tudor Health data are richer than many other sources.
Coverage of patients from all treatment settings, including specific target institutions if required.
Patients in all countries and across all specialties, including rare and very uncommon genetic conditions.
treatment settings, including specific target institutions if required
There has been increased discussion in the USA in the past week regarding…
Introduction In a previous paper we discussed how Tudor Health data is being used…
Understanding Health Equity Let’s explore the significance of health equity and why it…
Our data is sourced from all countries and specifically targets small cohorts and rare diseases, making it perfect for commercial use.
Tudor Health Inc, 1100 H St NW, Suite E-101, Washington DC 20005, USA
Simply enter your name and email below to receive occasional emails with news and industry insight.*
*Your information will only be used to send our newsletter. It wont be sold or passed to any third party. Obviously, you can unsubscribe at any time!